Diabetes, Vol 44, Issue 12 1438-1446, Copyright © 1995 by American Diabetes Association

ARTICLES

Effects of diabetes and hyperglycemia on the hexosamine synthesis pathway in rat muscle and liver

KA Robinson, ML Weinstein, GE Lindenmayer and MG Buse
Department of Medicine, Medical University of South Carolina, Charleston 29425, USA.

In vitro studies suggested that increased flux of glucose through the hexosamine biosynthesis pathway (HexNSP) contributes to glucose-induced insulin resistance. Glutamine:fructose-6- phosphate amidotransferase (GFAT) catalyzes glucose flux via HexSNP; its major products are uridine diphosphate (UDP)-N-acetyl hexosamines (UDP-HexNAc). We examined whether streptozotocin (STZ)-induced diabetes (4-10 days) or sustained hyperglycemia (1-2 h) in normal rats alters absolute or relative concentrations of nucleotide-linked sugars in skeletal muscle and liver in vivo. UDP-HexNAc and UDP-hexoses (UDP-Hex) were increased and decreased, respectively, in muscles of diabetic rats, resulting in an approximately 50% increase in the UDP-HexNAc:UDPHex ratio (P < 0.01). No significant changes in nucleotide sugars were observed in livers of diabetic rats. In muscles of normal rats, UDP-HexNAc concentrations increased (P < 0.01) and UDP-Hex decreased (P < 0.01) during hyperglycemia. The UDP-HexNAc:UDP-Hex ratio increased approximately 40% (P < 0.01) and correlated strongly with plasma glucose concentrations. Changes in liver were similar to muscle but were less marked. GFAT activity in muscle and liver was unaffected by 1-2 h of hyperglycemia. GFAT activity decreased 30-50% in muscle, liver, and epididymal fat of diabetic rats, and this was reversible with insulin therapy. No significant change in GFAT mRNA expression was detected, suggesting post-transcriptional regulation. The data suggest that glucose flux via HexNSP increases in muscle during hyperglycemic hyperinsulinemia and that the relative flux of glucose via HexNSP is increased in muscle in STZ-induced diabetes.(ABSTRACT TRUNCATED AT 250 WORDS)
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. Liu, R. B. Marchase, and J. C. Chatham Increased O-GlcNAc levels during reperfusion lead to improved functional recovery and reduced calpain proteolysis Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1391 - H1399. [Abstract] [Full Text] [PDF]

				N. Fulop, Z. Zhang, R. B. Marchase, and J. C. Chatham Glucosamine cardioprotection in perfused rat hearts associated with increased O-linked N-acetylglucosamine protein modification and altered p38 activation Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2227 - H2236. [Abstract] [Full Text] [PDF]

				N. Fulop, M. M. Mason, K. Dutta, P. Wang, A. J. Davidoff, R. B. Marchase, and J. C. Chatham Impact of Type 2 diabetes and aging on cardiomyocyte function and O-linked N-acetylglucosamine levels in the heart Am J Physiol Cell Physiol, April 1, 2007; 292(4): C1370 - C1378. [Abstract] [Full Text] [PDF]

				V. Champattanachai, R. B. Marchase, and J. C. Chatham Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein-associated O-GlcNAc Am J Physiol Cell Physiol, January 1, 2007; 292(1): C178 - C187. [Abstract] [Full Text] [PDF]

				M. G. Buse Hexosamines, insulin resistance, and the complications of diabetes: current status Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E1 - E8. [Abstract] [Full Text] [PDF]

				T. Nagy, V. Champattanachai, R. B. Marchase, and J. C. Chatham Glucosamine inhibits angiotensin II-induced cytoplasmic Ca2+ elevation in neonatal cardiomyocytes via protein-associated O-linked N-acetylglucosamine Am J Physiol Cell Physiol, January 1, 2006; 290(1): C57 - C65. [Abstract] [Full Text] [PDF]

				B. D. Lazarus, M. D. Roos, and J. A. Hanover Mutational Analysis of the Catalytic Domain of O-Linked N-Acetylglucosaminyl Transferase J. Biol. Chem., October 21, 2005; 280(42): 35537 - 35544. [Abstract] [Full Text] [PDF]

				C. Weigert, C. Thamer, K. Brodbeck, A. Guirguis, F. Machicao, J. Machann, F. Schick, M. Stumvoll, A. Fritsche, H. U. Haring, et al. The -913 G/A Glutamine:Fructose-6-Phosphate Aminotransferase Gene Polymorphism Is Associated with Measures of Obesity and Intramyocellular Lipid Content in Nondiabetic Subjects J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1639 - 1643. [Abstract] [Full Text] [PDF]

				Y. Wei and M. J. Pagliassotti Hepatospecific effects of fructose on c-jun NH2-terminal kinase: implications for hepatic insulin resistance Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E926 - E933. [Abstract] [Full Text] [PDF]

				Z. T. Kneass and R. B. Marchase Neutrophils Exhibit Rapid Agonist-induced Increases in Protein-associated O-GlcNAc J. Biol. Chem., October 29, 2004; 279(44): 45759 - 45765. [Abstract] [Full Text] [PDF]

				M.-J. J. Pouwels, C. J. Tack, P. N. Span, A. J. Olthaar, C. G. J. Sweep, F. C. Huvers, J. A. Lutterman, and A. R. M. M. Hermus Role of Hexosamines in Insulin Resistance and Nutrient Sensing in Human Adipose and Muscle Tissue J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 5132 - 5137. [Abstract] [Full Text] [PDF]

				M. Hazel, R. C. Cooksey, D. Jones, G. Parker, J. L. Neidigh, B. Witherbee, E. A. Gulve, and D. A. McClain Activation of the Hexosamine Signaling Pathway in Adipose Tissue Results in Decreased Serum Adiponectin and Skeletal Muscle Insulin Resistance Endocrinology, May 1, 2004; 145(5): 2118 - 2128. [Abstract] [Full Text] [PDF]

				Y. Pang, P. Bounelis, J. C. Chatham, and R. B. Marchase Hexosamine Pathway Is Responsible for Inhibition by Diabetes of Phenylephrine-Induced Inotropy Diabetes, April 1, 2004; 53(4): 1074 - 1081. [Abstract] [Full Text] [PDF]

				N. Shanmugam, I. T. Gaw Gonzalo, and R. Natarajan Molecular Mechanisms of High Glucose-Induced Cyclooxygenase-2 Expression in Monocytes Diabetes, March 1, 2004; 53(3): 795 - 802. [Abstract] [Full Text] [PDF]

				D.-H. Han, M. M. Chen, and J. O. Holloszy Glucosamine and glucose induce insulin resistance by different mechanisms in rat skeletal muscle Am J Physiol Endocrinol Metab, December 1, 2003; 285(6): E1267 - E1272. [Abstract] [Full Text] [PDF]

				R. J. Clark, P. M. McDonough, E. Swanson, S. U. Trost, M. Suzuki, M. Fukuda, and W. H. Dillmann Diabetes and the Accompanying Hyperglycemia Impairs Cardiomyocyte Calcium Cycling through Increased Nuclear O-GlcNAcylation J. Biol. Chem., November 7, 2003; 278(45): 44230 - 44237. [Abstract] [Full Text] [PDF]

				C. Weigert, K. Klopfer, C. Kausch, K. Brodbeck, M. Stumvoll, H. U. Haring, and E. D. Schleicher Palmitate-Induced Activation of the Hexosamine Pathway in Human Myotubes: Increased Expression of Glutamine:Fructose-6-Phosphate Aminotransferase Diabetes, March 1, 2003; 52(3): 650 - 656. [Abstract] [Full Text] [PDF]

				M.-J. J. Pouwels, P. N. Span, C. J. Tack, A. J. Olthaar, C. G. J. Sweep, B. G. van Engelen, J. G. de Jong, J. A. Lutterman, and A. R. Hermus Muscle Uridine Diphosphate-Hexosamines Do Not Decrease Despite Correction of Hyperglycemia-Induced Insulin Resistance in Type 2 Diabetes J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5179 - 5184. [Abstract] [Full Text] [PDF]

				M. G. Buse, K. A. Robinson, B. A. Marshall, R. C. Hresko, and M. M. Mueckler Enhanced O-GlcNAc protein modification is associated with insulin resistance in GLUT1-overexpressing muscles Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E241 - E250. [Abstract] [Full Text] [PDF]

				K. O. Broschat, C. Gorka, J. D. Page, C. L. Martin-Berger, M. S. Davies, H.-c. Huang, E. A. Gulve, W. J. Salsgiver, and T. P. Kasten Kinetic Characterization of Human Glutamine-fructose-6-phosphate Amidotransferase I. POTENT FEEDBACK INHIBITION BY GLUCOSAMINE 6-PHOSPHATE J. Biol. Chem., April 19, 2002; 277(17): 14764 - 14770. [Abstract] [Full Text] [PDF]

				K. Sasai, Y. Ikeda, T. Fujii, T. Tsuda, and N. Taniguchi UDP-GlcNAc concentration is an important factor in the biosynthesis of {beta}1,6-branched oligosaccharides: regulation based on the kinetic properties of N-acetylglucosaminyltransferase V Glycobiology, February 1, 2002; 12(2): 119 - 127. [Abstract] [Full Text] [PDF]

				M. Nakamura, A. J. Barber, D. A. Antonetti, K. F. LaNoue, K. A. Robinson, M. G. Buse, and T. W. Gardner Excessive Hexosamines Block the Neuroprotective Effect of Insulin and Induce Apoptosis in Retinal Neurons J. Biol. Chem., November 16, 2001; 276(47): 43748 - 43755. [Abstract] [Full Text] [PDF]

				J. E. DeHaven, K. A. Robinson, B. A. Nelson, and M. G. Buse A Novel Variant of Glutamine: Fructose-6-Phosphate Amidotransferase-1 (GFAT1) mRNA Is Selectively Expressed in Striated Muscle Diabetes, November 1, 2001; 50(11): 2419 - 2424. [Abstract] [Full Text] [PDF]

				M.-J. J. Pouwels, J. R. Jacobs, P. N. Span, J. A. Lutterman, P. Smits, and C. J. Tack Short-Term Glucosamine Infusion Does Not Affect Insulin Sensitivity in Humans J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2099 - 2103. [Abstract] [Full Text]

				P. N. Span, M.-J. J.M. Pouwels, A. J. Olthaar, R. R. Bosch, A. R.M.M. Hermus, and C.G.J. Sweep Assay for Hexosamine Pathway Intermediates (Uridine Diphosphate-N-Acetyl Amino Sugars) in Small Samples of Human Muscle Tissue Clin. Chem., May 1, 2001; 47(5): 944 - 946. [Full Text] [PDF]

				C. S. Choi, F. N. Lee, and J. H. Youn Free Fatty Acids Induce Peripheral Insulin Resistance Without Increasing Muscle Hexosamine Pathway Product Levels in Rats Diabetes, February 1, 2001; 50(2): 418 - 424. [Abstract] [Full Text]

				E. D. Crook, G. Crenshaw, G. Veerababu, and L. P. Singh Overexpression of Glutamine:Fructose-6-Phosphate Amidotransferase in Rat-1 Fibroblasts Enhances Glucose-Mediated Glycogen Accumulation via Suppression of Glycogen Phosphorylase Activity Endocrinology, June 1, 2000; 141(6): 1962 - 1970. [Abstract] [Full Text] [PDF]

				A. C. Gazdag, T. J. Wetter, R. T. Davidson, K. A. Robinson, M. G. Buse, A. J. Yee, L. P. Turcotte, and G. D. Cartee Lower calorie intake enhances muscle insulin action and reduces hexosamine levels Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2000; 278(2): R504 - R512. [Abstract] [Full Text] [PDF]

				M. Hawkins, M. Hu, J. Yu, H. Eder, P. Vuguin, L. She, N. Barzilai, M. Leiser, J. M. Backer, and L. Rossetti Discordant Effects of Glucosamine on Insulin-stimulated Glucose Metabolism and Phosphatidylinositol 3-Kinase Activity J. Biol. Chem., October 29, 1999; 274(44): 31312 - 31319. [Abstract] [Full Text] [PDF]

				T. P. Ciaraldi, L. Carter, S. Nikoulina, S. Mudaliar, D. A. McClain, and R. R. Henry Glucosamine Regulation of Glucose Metabolism in Cultured Human Skeletal Muscle Cells: Divergent Effects on Glucose Transport/Phosphorylation and Glycogen Synthase in Non-Diabetic and Type 2 Diabetic Subjects Endocrinology, September 1, 1999; 140(9): 3971 - 3980. [Abstract] [Full Text]

				K. Kawanaka, D.-H. Han, L. A. Nolte, P. A. Hansen, A. Nakatani, and J. O. Holloszy Decreased insulin-stimulated GLUT-4 translocation in glycogen-supercompensated muscles of exercised rats Am J Physiol Endocrinol Metab, May 1, 1999; 276(5): E907 - E912. [Abstract] [Full Text] [PDF]

				R. C. Cooksey, L. F. Hebert Jr., J.-H. Zhu, P. Wofford, W. T. Garvey, and D. A. McClain Mechanism of Hexosamine-Induced Insulin Resistance in Transgenic Mice Overexpressing Glutamine:Fructose-6-Phosphate Amidotransferase: Decreased Glucose Transporter GLUT4 Translocation and Reversal by Treatment with Thiazolidinedione Endocrinology, March 1, 1999; 140(3): 1151 - 1157. [Abstract] [Full Text]

				K. A. Robinson, S. M. Willi, S. Bingel, and M. G. Buse Decreased hexosamine biosynthesis in GH-deficient dwarf rat muscle. Reversal with GH, but not IGF-I, therapy Am J Physiol Endocrinol Metab, March 1, 1999; 276(3): E435 - E442. [Abstract] [Full Text] [PDF]

				B. A. Marshall, P. A. Hansen, N. J. Ensor, M. A. Ogden, and M. Mueckler GLUT-1 or GLUT-4 transgenes in obese mice improve glucose tolerance but do not prevent insulin resistance Am J Physiol Endocrinol Metab, February 1, 1999; 276(2): E390 - E400. [Abstract] [Full Text] [PDF]

				M. Flores-Diaz, A. Alape-Giron, R. W. Titball, M. Moos, I. Guillouard, S. Cole, A. M. Howells, C. von Eichel-Streiber, I. Florin, and M. Thelestam UDP-glucose Deficiency Causes Hypersensitivity to the Cytotoxic Effect of Clostridium perfringens Phospholipase C J. Biol. Chem., September 18, 1998; 273(38): 24433 - 24438. [Abstract] [Full Text] [PDF]

				M. Flores-Diaz, A. Alape-Giron, B. Persson, P. Pollesello, M. Moos, C. von Eichel-Streiber, M. Thelestam, and I. Florin Cellular UDP-Glucose Deficiency Caused by a Single Point Mutation in the UDP-Glucose Pyrophosphorylase Gene J. Biol. Chem., September 19, 1997; 272(38): 23784 - 23791. [Abstract] [Full Text] [PDF]

				A. Virkamaki, M. C. Daniels, S. Hamalainen, T. Utriainen, D. McClain, and H. Yki-Jarvinen Activation of the Hexosamine Pathway by Glucosamine in Vivo Induces Insulin Resistance in Multiple Insulin Sensitive Tissues Endocrinology, June 1, 1997; 138(6): 2501 - 2507. [Abstract] [Full Text] [PDF]

				M. Hawkins, I. Angelov, R. Liu, N. Barzilai, and L. Rossetti The Tissue Concentration of UDP-N-acetylglucosamine Modulates the Stimulatory Effect of Insulin on Skeletal Muscle Glucose Uptake J. Biol. Chem., February 21, 1997; 272(8): 4889 - 4895. [Abstract] [Full Text] [PDF]

				M. G. Buse, K. A. Robinson, B. A. Marshall, and M. Mueckler Differential Effects of GLUT1 or GLUT4 Overexpression on Hexosamine Biosynthesis by Muscles of Transgenic Mice J. Biol. Chem., September 20, 1996; 271(38): 23197 - 23202. [Abstract] [Full Text] [PDF]

				K. Kawanaka, D.-H. Han, J. Gao, L. A. Nolte, and J. O. Holloszy Development of Glucose-induced Insulin Resistance in Muscle Requires Protein Synthesis J. Biol. Chem., June 1, 2001; 276(23): 20101 - 20107. [Abstract] [Full Text] [PDF]